Home  >  Products  >  SNRNP200 (small nuclear ribonucleoprotein 200kDa (U5) ) Blocking Peptide (the N terminal of SNRNP200)(100ug)
SNRNP200 (small nuclear ribonucleoprotein 200kDa (U5) ) Blocking Peptide (the N terminal of SNRNP200)(100ug)

SNRNP200 (small nuclear ribonucleoprotein 200kDa (U5) ) Blocking Peptide (the N terminal of SNRNP200)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SNRNP200 Antibody (ARP36414_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP36414
Size: 100ug
Weight: 244kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Pre-mRNA splicing is catalyzed by the spliceosome, a complex of specialized RNA and protein subunits that removes introns from a transcribed pre-mRNA segment. The spliceosome consists of small nuclear RNA proteins (snRNPs) U1, U2, U4, U5 and U6, together with approximately 80 conserved proteins. U5 snRNP contains nine specific proteins. This gene encodes one of the U5 snRNP-specific proteins. This protein belongs to the DEXH-box family of putative RNA helicases. It is a core component of U4/U6-U5 snRNPs and appears to catalyze an ATP-dependent unwinding of U4/U6 RNA duplices. Mutations in this gene cause autosomal-dominant retinitis pigmentosa.
Alternative names: ASCC3L1; BRR2; FLJ11521; HELIC2; RP33; U5-200KD
See Full Product Listings >